ArticleCell stress2026
Glycemia reprograms substrate transport and shapes divergent stress responses in differentiating H9c2 cells.
Article in Cell stress, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metabolic stress is a major determinant of cell fate, particularly during differentiation, when long-lasting adaptations shape cellular responses to subsequent insults. Early-life glycemic instability is increasingly recognized as a stressor capable of programming cardiomyocyte metabolism and vulnerability, yet its direct impact on stress-response pathways during cardiomyocyte differentiation remains poorly defined. Here, we used differentiating H9c2 cardiomyoblasts to model chronic hypoglycemic (2.5 mM), normoglycemic (5 mM), and hyperglycemic (30 mM) conditions as opposing metabolic challenges, and examined their effects on substrate transport, lipid homeostasis, and stress-induced cell death pathways. Both hypoglycemic and hyperglycemic stress reprogrammed phenotypes, but through distinct mechanisms. Hypoglycemic stress increased expression of the glucose transporter GLUT1, concomitantly enhancing functional glucose uptake. It also upregulated the fatty-acid transporter CD36 and carnitine palmitoyltransferase-1 (CPT1), indicating coordinated enhancement of substrate uptake and mitochondrial fatty-acid oxidation. In contrast, hyperglycemic stress suppressed GLUT1 expression and decreased glucose uptake, while increasing CD36 without upregulating CPT1. Under iso-osmotic conditions, this resulted in intracellular lipid accumulation consistent with an overload and lipotoxic stress. When challenged with anoxia-reoxygenation, hypoglycemia-conditioned cells predominantly engaged autophagy, as shown by increased LC3B-II/LC3B-I ratio, whereas hyperglycemia-conditioned cells exhibited enhanced apoptotic signaling, with increased caspase-3, PARP cleavage and DNA fragmentation. Notably, normoglycemic differentiation conferred the greatest resistance to oxygen fluctuations. Together, these findings demonstrate that chronic glycemic stress during cardiomyoblast differentiation programs divergent stress-response pathways, biasing cells toward autophagy or apoptosis in response to acute injury. This work highlights metabolic homeostasis as a critical determinant of cellular stress resilience and provides mechanistic insight into how early metabolic stress shapes cardiomyocyte vulnerability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.